Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in teenagers is hard to treat and lacks a cure, with some treatments available depending on the type of hair loss.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

Pembrolizumab can cause serious liver issues, requiring close monitoring and early treatment.

Different hair diseases affect people during childbearing years, with treatments ranging from medication to psychological support.

Cyclosporine may cause hair loss, so patients need monitoring.

IL-17 inhibitors for psoriasis may cause unexpected hair loss.

DM and AA may share a common cause.

Thyroid disease can cause skin, hair, and nail problems, and treating the thyroid condition often improves these symptoms.

GLP-1 receptor agonists can cause skin reactions, facial fat loss, and hair loss, but may help with wound healing and skin conditions.

A woman's complete hair loss condition improved after recovering from COVID-19.

Exosomes could be key in treating skin conditions and healing wounds.

Type I interferons play a key role in the development of various skin diseases.

Low vitamin D levels are common in people with Alopecia Areata.

A dog with unusual skin lesions near its tail was successfully treated for a rare form of lupus.

Ustekinumab significantly improved psoriasis, vitiligo, and alopecia areata in a patient.

Some patients receiving pegylated interferon alfa injections developed skin necrosis, requiring treatment adjustments or discontinuation.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Simvastatin/ezetimibe did not effectively treat severe alopecia areata and caused side effects in some patients.

Trichogram is useful for diagnosing hair disorders, but newer, non-invasive methods like trichoscopy are becoming more popular due to their sensitivity and ability to monitor treatment responses.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

Topical clobetasol is recommended over mycophenolate mofetil for treating Lichen Planopilaris due to better safety and patient satisfaction.

Intralesional Triamcinolone acetonide injections are safe and effective for treating alopecia areata.

Bimatoprost was found to be safer and more effective than mometasone furoate for treating scalp hair loss.

Intralesional triamcinolone acetonide is better than PRP for treating scalp alopecia areata, leading to faster and more complete hair regrowth.

Mitochondrial therapy and platelet-rich plasma therapy both stimulated hair regrowth in aging mice, with mitochondrial therapy showing similar effectiveness to plasma therapy.

Apremilast shows promise for several skin conditions but needs more research.

Mometasone furoate cream was more effective than bimatoprost solution for treating hair loss from Alopecia Areata.

Mycophenolate mofetil can effectively treat autoimmune hepatitis when standard drugs fail.